Tag: New drivers of export growth by Indian Pharma!

 New drivers of export growth by Indian Pharma!  by HDFC Asset Management Company Limited (HDFC AMC) India’s healthcare prowess is now well-recognised. With a lion’s share of 48% of all generic drugs sold in the US, I ndian generics are a key contributor in the US saving 1.6% of its GDP via use of generics and biosimilars. A growi ng global market has helped Indian exports of pharmaceutical formulations and biologicals grow at 8% CAGR in USD terms. The outlook for exports growth is enhanced by the current shortage of drugs in the US, expiring pate nts with large markets, and the potential growth in the biosimilars and contract development and manufacturing space. Growing strengths in manufacturing and research have solidified India’s position in the global market We would like to hig...